Sensitivity & scenario analyses are versatile — they are used to assess and predict the outcomes of any project, situation, or process that can be modeled quantitatively. At Helikon, we use our industry-specific knowledge to conduct sensitivity and scenario analyses of specialized bioprocesses, including those used by cell-based meat and precision fermentation companies. We can work with company R&D data to create company-specific bioprocess models that can demonstrate both current and future bioprocess capabilities.

The market for alternative proteins is one of the fastest up and coming markets today. According to the Good Food Institute, fermentation technology companies alone have garnered a $435 million investment in 2020 despite the coronavirus pandemic, and before the end of the calendar year. This is a 58% jump from 2019, which saw a $274 million investment in the field. This number expands to a $1.5 billion investment in alternative proteins more broadly, in 2020.